INTERNATIONAL PATENT: INVENTERA INC., 주식회사 인벤테라 FILES APPLICATION FOR "LYMPHATIC-DRAINING POLYSACCHARIDE CROSS-LINKED COLLOIDAL PARTICLE-BASED FUNCTIONAL DRUG HAVING REDUCED IMMUNOGENICITY"

GENEVA, Oct. 19 -- INVENTERA INC. (2F, 111 Seocho-daero,Seocho-gu,Seoul 06588), 주식회사 인벤테라 (서울특별시서초구서초대로 111, 2층) filed a patent application (PCT/KR2025/004884) for "LYMPHATIC-DRAINING POLYSACCHARIDE CROSS-LINKED COLLOIDAL PARTICLE-BASED FUNCTIONAL DRUG HAVING REDUCED IMMUNOGENICITY" on Apr 10, 2025. With publication no. WO/2025/216570, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Invento...